List View

By /

Clear

Displaying 2,151 - 2,175 of 2,995

Emerging Indications and Techniques in MSK Ablation

Emerging Indications and Techniques in MSK Ablation

Percutaneous Treatment of Bone Tumors – Case review

Percutaneous Treatment of Bone Tumors – Case review

Percutaneous Thermal Ablation of Vertebral Metastasis

Percutaneous Thermal Ablation of Vertebral Metastasis

Sexual Differences in the Experience of Acute Post Procedural Pain after Thermal LIver Ablations; a Retrospective Study

Sexual Differences in the Experience of Acute Post Procedural Pain after Thermal LIver Ablations; a Retrospective Study

Irreversible Electroporation in Hepatocellular Carcinomas Adjacent to Critical Anatomical Structures, a Single Centre Experience

Irreversible Electroporation in Hepatocellular Carcinomas Adjacent to Critical Anatomical Structures, a Single Centre Experience

Single Center Experience with Irreversible Electroporation for Locally Advanced Pancreatic Cancer

Single Center Experience with Irreversible Electroporation for Locally Advanced Pancreatic Cancer

The Novel Image Guided Percutaneous Management of Inoperable Cancer of the Head of Pancreas – Technique and Results

The Novel Image Guided Percutaneous Management of Inoperable Cancer of the Head of Pancreas – Technique and Results

Histotripsy Through Gas-Filled Colon and Small Bowel in an Ex Vivo Swine Model

Histotripsy Through Gas-Filled Colon and Small Bowel in an Ex Vivo Swine Model

Current role of systemic therapy in HCC

Current role of systemic therapy in HCC

Role of genomics, molecular biomarkers and AI in HCC therapy

Role of genomics, molecular biomarkers and AI in HCC therapy

Revisiting the indications for Surgery vs Ablation

Revisiting the indications for Surgery vs Ablation

Time to Transplant – An important factor in selection of liver directed therapy

Time to Transplant – An important factor in selection of liver directed therapy

Navigating locoregional treatment options in HCC

Navigating locoregional treatment options in HCC

Ablation with a curative intent in HCC

Ablation with a curative intent in HCC

Impact of c-TACE on the management of HCC

Impact of c-TACE on the management of HCC

Advances in DEB-TACE technology and clinical outcomes

Advances in DEB-TACE technology and clinical outcomes

Y90 in locally-advanced disease with PVT

Y90 in locally-advanced disease with PVT

3rd Annual James G. Caridi Lecture

3rd Annual James G. Caridi Lecture

Current systemic treatments – Chemotherapy, Immunotherapy & Target Agents

Current systemic treatments – Chemotherapy, Immunotherapy & Target Agents

Locoregional treatments in Cholangiocarcinoma

Locoregional treatments in Cholangiocarcinoma

How to incorporate molecular testing in therapy for localized disease

How to incorporate molecular testing in therapy for localized disease

Percutaneous ablation strategies in Cholangiocarcinoma

Percutaneous ablation strategies in Cholangiocarcinoma

Aiming for Better Outcomes: Comparing and Combining Systemic & Locoregional Therapies

Aiming for Better Outcomes: Comparing and Combining Systemic & Locoregional Therapies

Urology and IR working together – the NIH Experience

Urology and IR working together – the NIH Experience

Focal therapy options in Prostate Cancer

Focal therapy options in Prostate Cancer